Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cybin Inc
(NY:
CYBN
)
0.2570
-0.0080 (-3.02%)
Streaming Delayed Price
Updated: 11:09 AM EDT, Aug 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cybin Inc
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004
November 10, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Provides Progress Update on its CYB004-E Phase 1 Trial
November 10, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation Schedule for Upcoming Investor Events
November 03, 2022
Via
Investor Brand Network
Study Finds Using Social Media May Negatively Affect Youths’ Mental Health
September 21, 2022
Via
Investor Brand Network
Cybin to Participate in the Jefferies London Healthcare Conference and Upcoming Investor Events
November 03, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit
November 01, 2022
Via
Investor Brand Network
Cybin Announces Scientific Presentation at the 5th Annual Neuropsychiatric & Psychedelics Drug Development Summit
November 01, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Graduates Class of Facilitators
October 27, 2022
Via
Investor Brand Network
Cybin’s EMBARK Program Announces Graduation of Facilitators
October 27, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients
October 17, 2022
Via
Investor Brand Network
TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), The Chopra Foundation Note World Mental Health Day
October 11, 2022
Via
Investor Brand Network
Psychedelic Drugs Prove Their Worth In Clinical Trials
October 11, 2022
Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial...
Via
PressReach
Cybin & The Chopra Foundation Recognize World Mental Health Day
October 10, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) ‘Focused on Adding Targeted IP’
October 06, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Provides Update on its Intellectual Property Portfolio
October 06, 2022
From
Cybin Inc.
Via
Business Wire
Colorado to Vote on Legalizing Psychoactives in November
October 05, 2022
Voters in Colorado will have a say in the legalization of psychedelic drugs this November as an initiative to legalize psilocybin mushrooms and other naturally occurring psychedelics appears on the...
Via
PressReach
Topics
Supply Chain
Exposures
Supply Chain
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Enters Agreement to Obtain Novel Catalog of Psychedelic-Based Compounds
September 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Cybin Obtains Exclusive License to a Novel Catalog of Psychedelic-Based Compounds
September 27, 2022
From
Cybin Inc.
Via
Business Wire
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one week after San Francisco officially decriminalized psychedelics, a meeting was held by the City...
Via
PressReach
Atlanta Becomes Latest City to Consider Decriminalizing Psychedelics
September 22, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – September 22, 2022 – Atlanta just became the latest city to consider decriminalizing psychedelics. On September 12, just one...
Via
FinancialNewsMedia
BioMedNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation in Upcoming Scientific and Investor Conferences
September 21, 2022
Via
Investor Brand Network
Cybin to Participate in Upcoming Scientific and Investor Conferences
September 21, 2022
From
Cybin Inc.
Via
Business Wire
PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces R&B Milestones, Beats Anticipated Timeframe
September 20, 2022
Via
Investor Brand Network
Hamilton Morris Confirmed as Keynote Speaker at Convergence Psychedelic Conference
September 20, 2022
Via
Investor Brand Network
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Clinical Trial Marks ‘Tremendous’ Milestone as First Participants Receive Initial CYB003 Dose
September 20, 2022
Via
Investor Brand Network
Cybin Achieves Research and Development Milestones Ahead of Projected Timelines
September 20, 2022
From
Cybin Inc.
Via
Business Wire
Study Suggests Reported Psychedelics Microdosing Effects Are Due to User Expectancy
September 15, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development
September 14, 2022
Via
Investor Brand Network
Study Finds Hepatitis C Drugs May Help Alleviate Symptoms of PTSD
September 13, 2022
Via
Investor Brand Network
How Psychedelic Legalization, Decriminalization and Medicalization Differ
September 12, 2022
Via
Investor Brand Network
Topics
Law Enforcement
Exposures
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.